Dr. Brafman is currently an Assistant Professor in the School of Biological and Health Systems Engineering. He is a 2005 graduate of the University of California-Berkeley in Bioengineering. Dr. Brafman received his Ph.D. in 2009 from the University of California-San Diego in Bioengineering where he was a NSF Graduate Research Fellow and UC BREP GREAT Fellow .
Dr. Christ has a broad interest in muscle physiology, intercellular communication and the role of muscle in the function and dysfunction of visceral, vascular and voluntary tissues (i.e., skeletal muscle). His research interests include physiological genomics, that is, establishing a verifiable link between changes in gene expression and alterations in cell/organ/tissue function/dysfunction, and then using this information to improve the understanding, diagnosis and treatment of smooth muscle diseases/disorders.
Dr. Feinberg joined CMU in the fall of 2010 as an Assistant Professor with joint appointments in Biomedical Engineering and Materials Science and Engineering. Dr. Feinberg earned a BS in Materials Science and Engineering from Cornell University in 1999, followed by a Masters (2002) and Ph.D. (2004) in Biomedical Engineering from the University of Florida, where his doctoral work was focused on engineering cell-material interactions to prevent and enhance adhesion.
Dr. Baraniak is a founding member of RoosterBio and has 20 years of experience in the tissue repair and regeneration arena, using pluripotent and multipotent stem cells and biomaterial scaffolds. Before joining RoosterBio, Priya was Senior Director of R&D for Garnet BioTherapeutics, a clinical-stage stem cell-based regenerative medicine company.
Ali Khademhosseini is the Levi Knight Professor of Bioengineering, Chemical Engineering and Radiology at the Univeristy of California-Los Angeles (UCLA). He is the Founding Director of the Center for Minimally Invasive Therapeutics at UCLA. In addition, he is an eminent scholar at Konkuk University in Korea.
American entrepreneur, engineer and inventor. In November 2000, at the age of 31, Michael acquired his first technology company, IDS Engineering. Today he is President & CEO of Advanced Solutions, Inc., which is a privately held company he acquired in November 2004, and parent company to an aggregate of technology businesses, including IDS Engineering.
Stephen Kennedy is the Chief Operating Officer and Executive VP of Histogenics. Mr. Kennedy joined Histogenics in 2013 with responsibilities over manufacturing, technology development and quality operations related to clinical development of its flagship product NeoCart, which is a tissue engineered autologous cartilage product.
Cato T. Laurencin, M.D., Ph.D., is a University Professor at the University of Connecticut (the 8th to be designated in the institution’s over 135 year history). He is the Albert and Wilda Van Dusen Distinguished Endowed Professor of Orthopaedic Surgery. He is Professor of Chemical, and Biomolecular Engineering, Professor of Materials Science and Engineering, and Professor of Biomedical Engineering at UConn.
Dr. Amy Peterson is an Associate Professor in Plastics Engineering at the University of Massachusetts Lowell. She received her PhD and BS in chemical engineering from Drexel University. Dr. Peterson did a postdoc at the Max Planck Institute of Colloids and Interfaces, and was a faculty member at WPI.
Lisa M Larkin, PhD, is an Associate Professor of Molecular & Integrative Physiology at the University of Michigan. She holds a joint appointment in the Biomedical Engineering Department at the University of Michigan. Dr. Larkin is co-director of the Skeletal Tissue Engineering Laboratory at the University of Michigan and has 28 years of expertise on musculoskeletal physiology and small and large animal surgical procedures and more than 15 years experience specifically with ligament, tendon, muscle and bone tissue engineering.
Dr. Melanie Matheu, PhD is a passionate research scientist turned entrepreneur with cross-disciplinary experience in Immunology, Chemistry, Biophysics, Molecular Biology, and Protein engineering. Dr. Matheu received her PhD in the department of Physiology and Biophysics from the University of California, Irvine where she pioneered imaging of immune responses in peripheral tissues including lung, spinal cord, skin, joints, as well as lymph nodes and spleen.
Dr. Taylor is leading international regenerative medicine research efforts, creating cutting edge therapies for chronic disease and “building the future treatments of tomorrow." An educator with over 25 years of teaching experience, she is truly committed to moving innovative therapies from bench to bedside, while preparing students/fellows to compete at an international level in the field of cardiac and vascular repair and regeneration.